Clinical Trial Update: Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab with dacarbazine and interferon-alfa for metastatic melanoma, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Avastin (bevacizumab)
• Dacarbazine (dacarbazine)
• Intron A (interferon alfa-2b)

Snippet

Sponsor: University of Turku | Conditions: Metastatic Melanoma | Phase 2 | Status: COMPLETED